Teleflex Incorporated $TFX Holdings Decreased by Citigroup Inc.

Citigroup Inc. reduced its position in shares of Teleflex Incorporated (NYSE:TFX) by 40.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,004 shares of the medical technology company’s stock after selling 14,020 shares during the period. Citigroup Inc.’s holdings in Teleflex were worth $2,570,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB boosted its holdings in Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 77 shares during the period. Hantz Financial Services Inc. raised its holdings in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Teleflex in the 3rd quarter worth about $35,000. True Wealth Design LLC lifted its position in shares of Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after buying an additional 310 shares during the last quarter. Finally, Quent Capital LLC acquired a new position in shares of Teleflex in the 3rd quarter valued at about $38,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Down 3.3%

Teleflex stock opened at $113.65 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. Teleflex Incorporated has a one year low of $100.18 and a one year high of $143.32. The company has a 50-day simple moving average of $110.97 and a 200-day simple moving average of $118.65. The firm has a market capitalization of $5.02 billion, a P/E ratio of -5.53, a P/E/G ratio of 0.76 and a beta of 0.87.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing the consensus estimate of $3.73 by ($1.80). The firm had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company’s revenue for the quarter was down 28.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.89 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 annualized dividend and a dividend yield of 1.2%. Teleflex’s payout ratio is currently -6.62%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Truist Financial boosted their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Wells Fargo & Company raised their target price on shares of Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th. Wall Street Zen downgraded Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Finally, Zacks Research cut Teleflex from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Teleflex currently has an average rating of “Hold” and a consensus target price of $140.83.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.